119 related articles for article (PubMed ID: 8162844)
1. [Individually risk-adapted antiemetic step therapy].
Bremer K
Dtsch Med Wochenschr; 1994 Apr; 119(16):598-604. PubMed ID: 8162844
[No Abstract] [Full Text] [Related]
2. Blueprint for the control of radiation-induced nausea and vomiting. Discussion.
Horiot JC
Acta Oncol; 2004 Sep; 43 Suppl 15():23-4. PubMed ID: 15370627
[No Abstract] [Full Text] [Related]
3. 5-HT3-receptor antagonists in the control of delayed-onset emesis.
Gridelli C
Anticancer Res; 2003; 23(3C):2773-82. PubMed ID: 12926112
[TBL] [Abstract][Full Text] [Related]
4. First choice for radiation-induced nausea and vomiting--the efficacy and safety of granisetron.
Goldsmith B
Acta Oncol; 2004 Sep; 43 Suppl 15():19-22. PubMed ID: 15370626
[No Abstract] [Full Text] [Related]
5. Is there a pharmacological basis for differences in 5-HT3-receptor antagonist efficacy in refractory patients?
de Wit R; Aapro M; Blower PR
Cancer Chemother Pharmacol; 2005 Sep; 56(3):231-8. PubMed ID: 15838653
[TBL] [Abstract][Full Text] [Related]
6. Site(s) and mechanisms of the anti-emetic action of 5-HT3 receptor antagonists: a discussion of Professor Naylor's paper.
Tyers MB
Br J Cancer Suppl; 1992 Dec; 19():S12-3. PubMed ID: 1467194
[No Abstract] [Full Text] [Related]
7. In search of the ideal antiemetic.
Seegenschmiedt MH
Acta Oncol; 2004 Sep; 43 Suppl 15():13-8. PubMed ID: 15370625
[No Abstract] [Full Text] [Related]
8. Optimising antiemetic therapy: what are the problems and how can they be overcome?
Aapro M
Curr Med Res Opin; 2005 Jun; 21(6):885-97. PubMed ID: 15969889
[TBL] [Abstract][Full Text] [Related]
9. Antiemetic drugs.
Cranwell-Bruce L
Medsurg Nurs; 2009; 18(5):309-13; quiz 314. PubMed ID: 19927970
[No Abstract] [Full Text] [Related]
10. [Type-3 serotonin receptor blockaders (5-HT3)--a new class of antiemetic preparations].
Legeza VI
Eksp Klin Farmakol; 1994; 57(4):72-5. PubMed ID: 7950795
[No Abstract] [Full Text] [Related]
11. Management of chemotherapy-related nausea and vomiting using a serotonin antagonist.
Egan AP; Taggart JR; Bender CM
Oncol Nurs Forum; 1992 Jun; 19(5):791-5. PubMed ID: 1535124
[TBL] [Abstract][Full Text] [Related]
12. 5-Hydroxytryptamine (serotonin) subtype 3 antagonists, a major step in prophylaxis and control of cytostatic and radiation-induced emesis.
Bremer K
J Cancer Res Clin Oncol; 1991; 117(1):85-7. PubMed ID: 1997476
[No Abstract] [Full Text] [Related]
13. 5HT3-antagonist receptors: their role in drug-induced emesis.
Dieras V; Extra JM; Le Bonniec M; Madelaine I; Espie M; Marty M
Nouv Rev Fr Hematol (1978); 1990; 32(6):449-52. PubMed ID: 1983228
[TBL] [Abstract][Full Text] [Related]
14. The vomiting reflex and the role of 5-HT3 receptors.
Freeman AJ; Bountra C; Dale TJ; Gardner CJ; Twissell DJ
Anticancer Drugs; 1993 Dec; 4 Suppl 2():9-15. PubMed ID: 7511008
[No Abstract] [Full Text] [Related]
15. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy.
Pradermdee P; Manusirivithaya S; Tangjitgamol S; Thavaramara T; Sukwattana P
J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140
[TBL] [Abstract][Full Text] [Related]
16. New antiemetic agents.
Gralla R
Clin Adv Hematol Oncol; 2005 May; 3(5):350-2, 382. PubMed ID: 16167009
[No Abstract] [Full Text] [Related]
17. Development of serotonin antagonists for the control of chemotherapy-induced emesis.
Hainsworth JD
Semin Surg Oncol; 1993; 9(3):279-84. PubMed ID: 8516617
[TBL] [Abstract][Full Text] [Related]
18. Nausea and vomiting with high-dose chemotherapy and stem cell rescue therapy: a review of antiemetic regimens.
Trigg ME; Inverso DM
Bone Marrow Transplant; 2008 Oct; 42(8):501-6. PubMed ID: 18724391
[TBL] [Abstract][Full Text] [Related]
19. Risk factors and antiemetic management of chemotherapy-induced nausea and vomiting.
Goodman M
Oncol Nurs Forum; 1997 Aug; 24(7 Suppl):20-32. PubMed ID: 9282378
[TBL] [Abstract][Full Text] [Related]
20. 5-HT3-receptor antagonists: a review of pharmacology and clinical efficacy.
Cunningham RS
Oncol Nurs Forum; 1997 Aug; 24(7 Suppl):33-40. PubMed ID: 9282379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
